Mode
Text Size
Log in / Sign up

Serial echocardiography in severe aortic regurgitation shows LVESD and FS changes predict riskDoes waiting for a specific heart measurement number actually keep you safe?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider LVESD and FS trends in severe aortic regurgitation as risk predictors, but interpret cautiously due to observational data.

This retrospective analysis included 140 patients with severe aortic regurgitation who underwent serial echocardiographic follow-up over a median of 93 months (interquartile range 58-130), with a 10-year projection. The intervention involved monitoring left ventricular parameters (LVESD, FS, LVEDD) compared to guideline-recommended thresholds, such as an LVEDD threshold of 65 mm. The primary outcome was a composite of symptom-driven aortic valve replacement, acute heart failure hospitalization, or death.

Main results showed that longitudinal trends included a small but statistically significant increase in LVESD and decrease in FS, while LVEDD did not show significant change. Risk analyses indicated that each 1 mm increase in LVESD was associated with a 6% increase in risk, each 1 mm increase in LVEDD with a 5% increase, and each 1% decrease in FS with a 12% increase. Age at onset was a strong predictor, with each decade increasing risk by 65%. Over 10 years, 8 patients (5.7%) were predicted to exceed the LVEDD threshold of 65 mm.

Safety and tolerability data were not reported. Key limitations include the observational design, which precludes causal inferences, and lack of reported effect sizes for some trends. The study suggests that AVR decisions should be based on comprehensive clinical and volumetric assessment rather than waiting for simple linear progression to guideline cutoffs, but findings require validation in prospective studies.

Many patients with severe aortic regurgitation live with a leaking heart valve, hoping their doctors will wait until the heart gets big enough to justify surgery. This study followed 140 of these patients for a median of nearly eight years to see what happened while they waited. The team tracked how their left ventricle changed over time using serial echocardiograms, which are repeated ultrasound scans of the heart.

They found that the heart did not stay perfectly still. The size of the heart muscle increased slightly, while its ability to squeeze decreased. More importantly, every small change mattered. For every millimeter the heart got wider, the risk of needing surgery, getting hospitalized, or dying went up by 5% to 6%.

The study also showed that older patients faced much higher risks, with risk climbing 65% for every decade of age. Only eight patients were predicted to reach the standard size limit for surgery within ten years. This means relying on a simple linear progression to a guideline cutoff might miss warning signs in many people.

The researchers conclude that decisions about valve replacement should be based on a comprehensive clinical and volumetric assessment rather than waiting for simple linear progression to guideline cutoffs. This approach ensures patients do not wait too long for help when their heart is already showing signs of trouble.

What this means for you:
Small changes in heart measurements predict higher risks, so doctors should assess the whole picture instead of just waiting for a number to hit a cutoff.

Study Details

Study typeCohort
Sample sizen = 140
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Guidelines recommend aortic valve replacement (AVR) in patients with severe aortic regurgitation (AR) based on progressive changes in left ventricular (LV) function or size. We aimed to reassess the clinical relevance of current guideline recommendations pertaining to traditional echocardiographic measurements in routine practice. METHODS: Retrospective analysis of patients with severe AR who underwent serial echocardiographic follow-up over at least 18 months. The composite outcome was symptom-driven AVR, acute heart failure hospitalization, or death. We used a joint modelling approach to handle within-subject correlation and censoring. RESULTS: The cohort consisted of 140 patients, with a median follow?up of 93 months (interquartile range 58?130). LV end-systolic (LVESD) and fractional shortening (FS) showed a small but statistically significant longitudinal trend, while LVEDD did not. Changes in all three parameters in parallel joint models adjusted for age and gender were consistently associated with increased risk of the composite event. Each 1?mm increase in LVESD and LVEDD was associated with a 6% and 5% increase in risk, respectively; each 1% decrease in FS corresponded to a 12% increase in risk. Only 8 (5.7%) of patients were predicted to exceed the guideline-recommended LVEDD threshold of 65 mm over 10 years. Age at onset was also a significant risk factor, with each decade increasing risk by 65% for each of the three parallel joint models. CONCLUSIONS: LV parameters show modest changes over time, despite holding strong prognostic value in patients with severe AR. LVEDD, while associated with overall risk, does not predictably or significantly dilate over time in most patients. AVR decisions should be based on comprehensive clinical and volumetric assessment rather than waiting for simple linear progression to guideline cutoffs.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.